Skip to main content
Ben Tomlinson, MD, Oncology, Cleveland, OH

Ben K Tomlinson MD

Hematologic Oncology


Physician

Join to View Full Profile
  • 11100 Euclid AveCleveland, OH 44106

  • Phone+1 216-844-3951

Dr. Tomlinson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of California Davis Health
    University of California Davis HealthFellowship, Hematology and Medical Oncology, 2012 - 2015
  • Case Western Reserve University School of Medicine
    Case Western Reserve University School of MedicineClass of 2009

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2010 - Present
  • OH State Medical License
    OH State Medical License 2015 - 2025
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Lymphoma-Specific Venous Thromboembolism Score (LyV-Score): Use of Lymphoma Subtype to Refine Risk Prediction
    Benjamin K. Tomlinson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Clinical and Immunologic Activity of Ipilimumab Following Decitabine Priming in Post-Allogeneic Transplant and Transplant-Na¥ve Patients with Relapsed or Refractory My...
    Benjamin K. Tomlinson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Feedback Responses of the Pyrimidine Metabolism Network Mediate Resistance to Decitabine and 5-Azacytidine
    Benjamin K. Tomlinson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Rapid reduction of peripheral blasts in older patients with refractory acute myeloid leukemia (AML) using reinduction with single agent anti-CD45 targeted iodine (I) a... 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: